Among them, it has been observed that, in vitro and using a common mouse model of psoriasis-like inflammation [60], Toll-like Receptor 4 (TLR4) signaling and the activation of IL-36 by neutrophils are able to enhance skin inflammation through NETs release. Here, TLR4 is linked to psoriasis.